Bristol-Myers Hit With Sanctions Bid Over Abilify Notebooks
A class of consumers suing drugmakers over side effects of the antipsychotic drug Abilify asked a Florida federal judge Monday to sanction defendant Bristol-Myers Squibb, alleging a pattern of obstructing discovery...To view the full article, register now.
Already a subscriber? Click here to view full article